Enterprise Value

1.576B

Cash

78.5M

Avg Qtr Burn

-21.23M

Short % of Float

8.88%

Insider Ownership

2.22%

Institutional Own.

69.04%

Qtr Updated

03/31/24


Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & IndicationStage & EventCatalyst Date

Approved

Update

Approved

Quarterly sales

Approved

Quarterly sales

Approved

Quarterly sales

Approved

Quarterly sales

Approved

Quarterly sales

Phase 1

Update

CHIKV VLP Details
Chikungunya, Viral infection

Failed

Discontinued

Failed

Discontinued

Failed

Discontinued